ProfileGDS4718 / 228985_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 42% 36% 36% 39% 32% 33% 28% 38% 36% 43% 32% 37% 39% 38% 37% 39% 37% 33% 39% 40% 38% 38% 40% 41% 40% 33% 37% 34% 35% 35% 37% 39% 40% 42% 35% 37% 37% 37% 38% 40% 43% 30% 38% 34% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1087442
GSM549102patient 115, normal, homogenized [OPG study]4.8069636
GSM549104patient 119, normal, homogenized [OPG study]4.808936
GSM549108patient 138, normal, homogenized [OPG study]4.9947439
GSM549119patient 077, normal, homogenized [OPG study]4.6415332
GSM549133patient 032, cancer, homogenized [OPG study]4.5971633
GSM549139patient 042, cancer, homogenized [OPG study]4.4445728
GSM549099patient 107, normal, homogenized [OPG study]4.9243438
GSM549109patient 139, normal, homogenized [OPG study]4.8398636
GSM549110patient 046, normal, homogenized [OPG study]5.1430843
GSM549114patient 063, normal, homogenized [OPG study]4.5993532
GSM549122patient 082, normal, homogenized [OPG study]4.8400137
GSM549134patient 033, cancer, homogenized [OPG study]4.9131139
GSM549136patient 036, cancer, homogenized [OPG study]4.8390538
GSM549140patient 044, cancer, homogenized [OPG study]4.8257437
GSM549111patient 047, normal, homogenized [OPG study]4.9107139
GSM549113patient 057, normal, homogenized [OPG study]4.811737
GSM549132patient 031, cancer, homogenized [OPG study]4.6418933
GSM549137patient 038, cancer, homogenized [OPG study]4.9367439
GSM549142patient 047, cancer, homogenized [OPG study]5.1086640
GSM549100patient 110, normal, homogenized [OPG study]4.9151638
GSM549107patient 135, normal, homogenized [OPG study]4.8539738
GSM549115patient 068, normal, homogenized [OPG study]4.9410340
GSM549116patient 072, normal, homogenized [OPG study]4.9972541
GSM549120patient 078, normal, homogenized [OPG study]5.0001440
GSM549131patient 030, cancer, homogenized [OPG study]4.6101533
GSM549118patient 074, normal, homogenized [OPG study]4.8470237
GSM549129patient 027, cancer, homogenized [OPG study]4.7461434
GSM549123patient 088, normal, homogenized [OPG study]4.7371535
GSM549124patient 006, cancer, homogenized [OPG study]4.8108435
GSM549126patient 015, cancer, homogenized [OPG study]4.8397237
GSM549128patient 025, cancer, homogenized [OPG study]4.9424339
GSM549103patient 117, normal, homogenized [OPG study]5.0371840
GSM549117patient 073, normal, homogenized [OPG study]5.0300642
GSM549138patient 041, cancer, homogenized [OPG study]4.7582235
GSM549141patient 045, cancer, homogenized [OPG study]4.76737
GSM549130patient 028, cancer, homogenized [OPG study]4.8479837
GSM549101patient 111, normal, homogenized [OPG study]4.8943637
GSM549105patient 128, normal, homogenized [OPG study]4.9008238
GSM549106patient 134, normal, homogenized [OPG study]4.9249740
GSM549112patient 048, normal, homogenized [OPG study]5.1526843
GSM549125patient 011, cancer, homogenized [OPG study]4.5464330
GSM549127patient 024, cancer, homogenized [OPG study]4.9097838
GSM549135patient 035, cancer, homogenized [OPG study]4.6774734